|Go to market news section|
blinkx plc announces that on 29 November 2012 Dr. Michael R Lynch, a Non-Executive Director, notified the Company that he had exercised options over 35,248 blinkx plc Ordinary Shares ('blinkx Shares') at an exercise price of £0.45 per share, and subsequently sold those blinkx Shares at a price of £0.6875 per share on 28 November 2012.
These share options were granted under the blinkx Autonomy Employee Discretionary Share Option Scheme 2007 by virtue of Dr Lynch's employment with Autonomy, and were scheduled to lapse if not exercised. Following this transaction, Dr Lynch has no share options in the Company. Dr. Lynch has an interest in 21,902,712 blinkx Shares, representing 6.0% of the Company's issued share capital.
For further information please contact:
Capita Company Secretarial Services
+44 (0) 207 954 9543
Citigroup Global Markets Ltd
NOMAD and Broker for blinkx
+44 (0)207 986 9756
London Stock Exchange plc is not responsible for and does not check content on this Website. Website users are responsible for checking content. Any news item (including any prospectus) which is addressed solely to the persons and countries specified therein should not be relied upon other than by such persons and/or outside the specified countries. Terms and conditions, including restrictions on use and distribution apply.
|©London Stock Exchange plc. All rights reserved|